Wegovy Not Curbing Appetite: Why It Happens and What Helps

You're two weeks in and your hunger feels exactly the same

That scenario is probably the most common message our prescribers receive. Someone has started Wegovy with realistic expectations, but two or three weeks on, meals feel no different and hunger is back by mid-afternoon just as before. The first thing worth knowing: at the early titration doses (0.25 mg and 0.5 mg) you are almost certainly not yet at a dose where meaningful appetite suppression is expected. The graduated schedule exists to reduce nausea and let your gut adapt, not to produce weight loss straight away. Patients who stop at this point often conclude the medicine does not work for them, when in fact they have not yet reached the dose at which clinical trials showed the strongest effect.

The STEP 1 trial, published in the New England Journal of Medicine, studied semaglutide 2.4 mg over 68 weeks, the maintenance dose, not the early rungs. Average weight loss around 15% came from participants who had completed the full titration. If you are early in that journey, patience is not complacency; it is clinically appropriate. That said, if nausea is severe, appetite is actually increasing, or you feel something is wrong, contact your prescribing team rather than waiting it out alone.

A simple check you can do right now: look at your last injection date and the dose on the pen label. If you are below 1.7 mg, you are still titrating. That context alone shifts the picture considerably.

Why appetite suppression can feel inconsistent even at higher doses

Some people reach 1.7 mg or 2.4 mg and still find hunger returning in ways they did not expect, particularly at certain times of day, around specific foods, or during periods of poor sleep or high stress. If you want a clearer sense of whether and how Wegovy curbs appetite across different people and doses, understanding the underlying mechanism helps make sense of why the effect can vary. This is not failure; it reflects how GLP-1 receptor signalling interacts with other appetite-regulating systems in the body.

Eating speed is one of the more overlooked factors. Semaglutide slows gastric emptying, which means fullness signals arrive more gradually than they did before treatment, but if meals are eaten quickly, you may finish before those signals catch up. The NHS patient information for semaglutide recommends eating slowly and stopping when comfortable, not when the plate is clear. That advice has a physiological basis on this medicine specifically.

Food composition also matters. Ultra-processed foods high in simple sugars and refined fats can override satiety signalling even in people whose semaglutide is working well biochemically. Alcohol similarly bypasses the fullness brake. Chronic sleep deprivation raises ghrelin (the hunger hormone) in ways that partially counteract GLP-1's effect. Our page on what to eat on Wegovy goes into this in more detail, the short version is that protein, fibre and slower eating pace tend to work with the medicine rather than against it.

When reduced appetite on Wegovy disappears over time

A distinct pattern some people notice is that appetite suppression was noticeable early on, then seemed to fade after several months. This is different from never feeling it at all. Some degree of physiological adaptation does occur (the body's response to a sustained level of any medicine can shift) though the clinical evidence does not support the idea that semaglutide simply stops working across the board after a fixed period. Our page covering what happens when you have no appetite on Wegovy also looks at the other end of this spectrum, where suppression becomes more intense than expected, which is equally worth understanding.

What the evidence does show is that interrupting treatment causes appetite to return relatively quickly. People who pause injections for more than a week or two often describe hunger returning with notable intensity before the next dose. If this pattern sounds familiar, it is worth discussing with your prescriber whether the relationship between Wegovy and appetite changes over time applies to your specific situation, and whether the 7.2 mg dose, approved by the MHRA in January 2026, might be clinically appropriate for you.

If you are at maintenance dose, have been consistent with injections, and genuinely feel no appetite suppression after six or more weeks, that is information a prescriber needs. NICE guidance on semaglutide (TA875) includes a clinical review point at six months; if meaningful weight change has not occurred, continuing treatment warrants careful assessment. Your prescriber (not a forum, not a comparison website) is the right place to have that conversation. The team at our GPhC-registered clinical pharmacy carries out exactly those reviews before every repeat is dispensed.

What else might look like appetite suppression not working

Sometimes the issue is not appetite at all, it is something that looks like appetite. Emotional eating, habitual eating (the hand in the crisp packet while watching television), and eating in response to boredom or anxiety are driven by different brain circuits from homeostatic hunger. Semaglutide acts on hunger and fullness; it has less consistent impact on these behavioural patterns, though some people report that cravings reduce too. If what you are experiencing is eating despite not being hungry, rather than being hungry despite the injection, that is a meaningful distinction worth raising.

It is also worth noting that the degree of appetite suppression does not perfectly predict weight outcomes. Some people lose significant weight with only modest hunger reduction because they become more aware of portion sizes and eating pace. Others feel dramatically less hungry but find other factors still affect their progress. The medicine is one part of a bigger picture. If you are finding the appetite effect underwhelming, reading more about why Wegovy may not be suppressing appetite as expected, or exploring how different treatment approaches compare, can help you bring a more specific question to your next clinical review.

If you have not yet started treatment or are wondering whether Wegovy is the right option for you, our free consultation is reviewed the same day by a named prescriber (a real clinician reads your answers, not an automated system) and prescription, delivery and ongoing aftercare are all included in one price with nothing added later. Finding Wegovy through a verified, regulated pharmacy matters particularly if you are weighing up why the medicine does or does not seem to be working; clinical continuity is part of that.